OTCQX:MRVFF - Post by User
Comment by
HippygirL74on Feb 12, 2010 12:48pm
410 Views
Post# 16780759
RE: RE: RE: Why such a focus
RE: RE: RE: Why such a focusdaydream1, the goal is to find an advantage over Voltaren Gel. If the animal studies pan out the market is opened up more. Even if patent protection ends, it would still take years for another product to reach the market, by which time, Pennsaid Plus should be available. A product doesn't have to be first to market to be successful, we might do quite well. i'm sure Covidien will be doing whatever is possible to get Pennsaid Plus with the labelling they desire with the data required to give it a big advantage over Volteren Gel.
As for your comment on Greece? Well the target is America and not Greece. People are getting older, and will develop chronic illnesses like OA with increasing numbers. This is a pure growth market. And NRI does not need to raise money for a long long time, so no matter what happens to the global economy, NRI will still be around.
Would you sell at
.15 when you have about
.11 in cash. i would be buying if we ever got that low and i'm sure a lot of smart people would be doing the same. Got to stay long imo. EARTH.